Pharmaceutical Quality (Industry)
1.0.0 - STU1 International flag

This page is part of the Pharmaceutical Quality (Industry) (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

: Composition - Drug - example, risk - TTL Representation

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:Composition ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "composition-drug-pq-risk"] ; # 
  fhir:meta [
    ( fhir:profile [
fhir:v "http://hl7.org/fhir/uv/pharm-quality/StructureDefinition/Composition-drug-pq"^^xsd:anyURI ;
fhir:link <http://hl7.org/fhir/uv/pharm-quality/StructureDefinition/Composition-drug-pq>     ] )
  ] ; #     Based on Accumulus FHIR Product Example - Drug Product 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Composition</b><a name=\"composition-drug-pq-risk\"> </a><a name=\"hccomposition-drug-pq-risk\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition &quot;composition-drug-pq-risk&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Composition-drug-pq.html\">Composition - Drug PQ</a></p></div><p><b>status</b>: final</p><p><b>type</b>: Product Note - Summary for Risk of Impurities <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>date</b>: 2023-10-01</p><p><b>author</b>: <a href=\"Organization-organization-drug-pq-ex1.html\">Organization/organization-drug-pq-ex1</a> &quot;AAA Molybdenum Products, Inc.&quot;</p><p><b>title</b>: 3.2.P.2.2.4 - Summary for Risk of Impurities</p></div>"
  ] ; # 
  fhir:status [ fhir:v "final"] ; # 
  fhir:type [
fhir:text [ fhir:v "Product Note - Summary for Risk of Impurities" ]
  ] ; # 
  fhir:subject ( [
fhir:reference [ fhir:v "MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1" ]
  ] ) ; # 
  fhir:date [ fhir:v "2023-10-01"^^xsd:date] ; # 
  fhir:author ( [
fhir:reference [ fhir:v "Organization/organization-drug-pq-ex1" ]
  ] ) ; # 
  fhir:title [ fhir:v "3.2.P.2.2.4 - Summary for Risk of Impurities"] ; # 
  fhir:section ( [
fhir:text [
fhir:status [ fhir:v "additional" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n                <p>Text for the risk assessment of elemental impurities in the product</p>\n            </div>"     ]
  ] ) . #